Consonance Capital Management LP Pacific Biosciences Of California, Inc. Transaction History

Consonance Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $16.7 Million - $18.2 Million	-2,455,114 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $44.1 Million - $86.5 Million	-11,057,844 Reduced 81.83%	2,455,114 $18.2 Million
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $3.3 Million - $5.2 Million	936,956 Added 7.45%	13,512,958 $73.1 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $11.3 Million - $17.8 Million	5,510,082 Added 77.98%	12,576,002 $25.8 Million
Q4 2017 Feb 14, 2018	BUY	$2.59 - $5.44 $426,034 - $894,836	164,492 Added 2.38%	7,065,920 $18.7 Million
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $22.1 Million - $38.4 Million	6,901,428	6,901,428 $36.2 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.